Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Generalized oedema


Published on

Published in: Health & Medicine
  • Be the first to comment

Generalized oedema

  1. 1. Clinical approach to a patient with generalized oedema<br />
  2. 2. Introduction<br />Oedemaisdefined as the accumulation of abnormallyexcessfluid in the interstitialspaces.<br />It canbeclassified as eithergeneralized or localized. (In thispresentationwewilldiscussgeneralizedoedema).<br />Oedemacanalsobeclassified as pitting and non-pitting.<br />
  3. 3. Mechanisms maintaining Interstitial Fluid Volume<br />The volume of interstitial fluid is determined by Starling's law: <br />Hydrostatic pressure - Oncotic pressure<br /> = <br /> Net fluid movement out of capillary into the interstitium<br />
  4. 4. Mechanisms maintaining Interstitial Fluid Volume<br />[Oncotic pressure = osmotic pressure created by plasma protein molecules (P) that are impermeable across the capillary membrane].<br />
  5. 5. Etiology of generalized oedema<br />Decreased plasma oncotic pressure: due to depletion of plasma proteins. This occurs in nephrotic syndrome, liver failure and malnutrition.<br />Obstruction of lymphatic flow: this occurs in congestive heart failure.<br />
  6. 6. Etiology of generalized oedema<br />3. Increased small vessel permeability: due to release of chemical mediators. Plasma proteins (P) leave the circulation and draws more water in the interstitial spaces. This occurs in allergic reactions as anaphylaxis, asthma, hay fever.<br />
  7. 7. Etiology of generalized oedema<br />4. Increased hydrostatic pressure: this causes more water to be driven outwards in the interstitial spaces. This occurs in congestive heart failure, liver cirrhosis, renal disease.<br />
  8. 8. To sum up…<br /> The causes of generalizedoedema are:<br />Cardiac cause: Congestive heartfailure.<br />Renal cause: Nephrotic syndrome.<br />Hepatic cause: Livercirrhosis.<br />Nutritional cause: Malnutrition.<br />Allergicreaction.<br />Drug-induced.<br />
  9. 9. Oedema of cardiac origin<br /><ul><li>In congestive heart failure, there is an increase in the central venous pressure. </li></ul> Besides, there is a decrease in renal perfusion which leads to:<br /><ul><li>Renin
  10. 10. Renal vasoconstriction
  11. 11. ADH</li></ul>Net result is an increase in hydrostatic pressure<br />
  12. 12. Oedema of cardiac origin<br />Characteristics of oedema of cardiac origin:<br />- Occurs in the lower extremities.<br /><ul><li>Symmetrical location.
  13. 13. Painless, pitting.
  14. 14. The presence of a heart disease: dyspnea, cardiac enlargement, hepatomegaly (tender).
  15. 15. There can be an elevated jugular venous pressure.</li></li></ul><li>Oedema of renal origin<br /><ul><li>Nephrotic syndrome is defined as a glomerular disease that results in proteinuria(urinary protein loss of ≥ 3.5 gm/day), hypoproteinemia, oedema, and hyperlipidemia.
  16. 16. Hypoalbuminemia due to urinary protein losses favors fluid movement from the intravascular to the interstitial compartment and exacerbates oedema formation in the nephrotic syndrome.
  17. 17. In some patients, urinary protein loss and hypoalbuminemia can be so severe that plasma volume becomes reduced, leading to renal hypoperfusion and further stimulating sodium and water retention.</li></li></ul><li>Oedema of renal origin<br />Characteristics of oedema of renal origin:<br /><ul><li>Mainly due to hypoalbuminemia and salt/water retention.</li></ul>- Associated with hematuria, proteinuria, <br /> hypertension and impaired renal functions.<br />- Associated with: puffiness of the face and prominent in the periorbital areas.<br />
  18. 18. Cardiac / Renal disease<br />Cardiac <br />Renal<br />Starts from the lower part of the body.<br />Slow progression.<br />Signs of heart failure: cardiac enlargement, venous distension, hepatomegaly.<br />Starts from the face and periorbital areas.<br />Quick progression.<br />Proteinuria, hypertension, impaired renal function tests.<br />Location:<br />Progression:<br />Other signs:<br />
  19. 19. Oedema of hepatic origin<br /><ul><li>Liver cirrhosis is defined as increased fibrous tissue in the liver associated with regeneration of focal areas of damaged liver parenchyma.
  20. 20. If severe, scarring and distortion of normal liver architecture can lead to marked hepatic dysfunction. This leads to a decrease in plasma protein production from the liver.
  21. 21. This, in turn, can cause sodium retention and oedema formation.
  22. 22. It appears that the damaged liver fails to degrade or overproduces vasodilating factors. This activates compensatory mechanisms such as sympathetic nerves and the renin-angiotensin-aldosterone system.</li></li></ul><li>Oedema of hepatic origin<br />Characteristics of oedema of hepatic origin:<br />- Clinical evidence of hepatic disease as <br />spider angioma , jaundice , ascites (refractory to treatment).<br />
  23. 23. Drug-induced oedema<br />Some drugs can lead to oedema as:<br /><ul><li>Non-steroidal inflammatory drugs.
  24. 24. Antihypertensive drugs: calcium channel blockers, alpha-adrenergic antagonists.
  25. 25. Steroid hormones.
  26. 26. Cyclosporine.
  27. 27. Growth hormone.</li></li></ul><li>Investigations<br /><ul><li>Urine Analysis
  28. 28. Heavy proteinuria with nephrotic syndrome.
  29. 29. FBC
  30. 30. Hb decreased in malabsorption.
  31. 31. U&Es
  32. 32. Elevated urea and creatinine in renal failure.
  33. 33. LFTs
  34. 34. Abnormal in liver disease.</li></li></ul><li>Investigations<br /><ul><li>Serum Albumin
  35. 35. Decreased with nephrotic syndrome, liver disease, malabsorption & malnutrition.
  36. 36. Renal Biopsy
  37. 37. To determine the cause of nephrotic syndrome in adults.
  38. 38. Echocardiography
  39. 39. Liver Biopsy
  40. 40. Faecal Fat Estimation
  41. 41. Increased in malabsorption.
  42. 42. Lymphangiography</li></li></ul><li>Treatment of generalized oedema<br />Treatment of the underlying cause.<br />Decrease sodium and water intake.<br />Increaseexcretion of sodium and water by the use of diuretics and bedrest.<br />Fluid restriction:<br /><ul><li>An edema forming patient typically loses little sodium from his/her body - about 15 mEq/day in urine, sweat and stool combined.
  43. 43. Thus restricting dietary salt often does not decrease oedema, it only prevents edema from becoming worse.</li></li></ul><li>Diuretics<br />These are drugsthatincrease the volume of urine.<br />Diuretics in common use include:<br /><ul><li>Thiazidediuretics.
  44. 44. Loopdiuretics.
  45. 45. Potassium-sparingdiuretics.</li></ul>Common sideeffects to anydiuretic:<br /><ul><li>Allergy.
  46. 46. GIT irritation.
  47. 47. Electrolytedisturbance: hypokalemia (except K-sparing).
  48. 48. Nephritis (exceptloopdiuretics).
  49. 49. Specificsideeffects to each type.</li></li></ul><li>Mechanism of action<br />Thiazides(acts mainly on proximal part of distal convoluted tubule).<br />Inhibits active reabsorption of Na and Clin the cortical diluting segment of the ascending loop of Henle.<br />K-sparing diuretics<br />Inhibits Na/K exchange in the<br />late distal convoluted and collecting tubule<br />Loop diuretics <br />Inhibit exchange of Na/K/Cl in<br /> the thick segment of the ascending <br />loop of Henle<br />Loop of Henle<br />Collecting tubule<br />
  50. 50. Thiazide diuretics<br />Indications:<br /><ul><li>Oedema (cardiac, hepatic, renal). It is the drug of choice in mild and moderate congestive heartfailure.
  51. 51. Hypertension.
  52. 52. Idiopathichypercalcuria.</li></ul>Sideeffects:<br /><ul><li>Hypokalemia, hyponatremia, hyperuricemia, hyperglycemia, hyperlipidemia.
  53. 53. It decreasesrenalblood flow.
  54. 54. Causes hypercalcemia.
  55. 55. Blood dyscriasis.</li></li></ul><li>Loop diuretics<br />Indications:<br /><ul><li>Oedema (cardiac, hepatic, renal). It is for Emergency use. In pulmonaryoedema, cerebraloedema, refractoryoedema.
  56. 56. Hypertension.
  57. 57. Hypercalcemia.
  58. 58. Acute renalfailure.</li></li></ul><li>Loop diuretics<br />Sideeffects: <br /><ul><li>Hypokalemia, hyponatremia, hyperuricemia, hyperglycemia, hyperlipidemia.
  59. 59. Ototoxic deafness.
  60. 60. Hypocalcemia.
  61. 61. Blood dyscriasis.</li></ul>There are twophenomenonsthat are known to occur:<br /><ul><li>Rebound phenomenon: a decrease in sodium excretion below baseline after the effect of the loop diuretic has worn off. Volume depletion activates the sodium retaining mechanisms.
  62. 62. Braking phenomenon</li></li></ul><li>Contraindications to the use of thiazides and loop diuretics<br />In the following conditions, it is contraindicated to use thiazides and loop diuretics:<br /><ul><li>Digitalis toxicity.
  63. 63. With steroids (because steroids cause Na and water retention).
  64. 64. Gout.
  65. 65. Diabetes mellitus.
  66. 66. Renal diseases (for thiazides).
  67. 67. Liver disease.
  68. 68. Pregnancy.</li></li></ul><li>Potassium-sparing diuretics<br />Spironolactoneis an aldosteroneantagonist. <br />Indications:<br /><ul><li>Refractoryoedema (in combinationwithotherdiuretics): hyperaldosteronism, nephroticoedema, Livercirrhosis + ascites.
  69. 69. Essential hypertension.
  70. 70. Instead of thiazides and loopdiureticswhenthey are contraindicated.</li></li></ul><li>Potassium-sparing diuretics<br />Sideeffects:<br /><ul><li>Gynecomastia and impotence in males. Irregular menstruation and ovulation in females.
  71. 71. Mental confusion and drowsiness.
  72. 72. Hyperkalemia.</li></ul>Contraindications:<br /><ul><li>Renalinsufficiency.
  73. 73. Hyperkalemia.
  74. 74. Concomitant use withamiloride and triamterene hyperkalemia.</li></li></ul><li>Diuretic resistance<br />Development of resistance to the action of diureticscanoccur due to:<br />- Neurohormonalactivation.<br />- ReboundNa+uptakeaftervolumeloss.<br />- Hypertrophy of distal nephron.<br />- Reduced tubular secretion(renal failure, NSAIDs).<br />- Decreased renal perfusion (low output).<br />- Alteredabsorption of thediuretic.<br />- Noncompliancewithdrugs.<br />
  75. 75. Managing diuretic resistance<br /><ul><li>Restrict sodium and water intake.
  76. 76. Increase dose (individual dose, frequency, i.v.).
  77. 77. Combine: furosemide + thiazide/spironolactone/metolazone.
  78. 78. Dopamine (increase cardiac output).
  79. 79. Reduce dose of ACE inhibitors.
  80. 80. Ultrafiltration.</li></li></ul><li>Thankyou<br />